Sequential chemoradiation and surgery for nasal rhabdomyosarcoma
Part of Cancer, Ear, nose & throat clinical trials.
This trial tests a treatment plan of chemotherapy, radiation, and then surgery for adults with rhabdomyosarcoma in the nose or sinus cavities. It aims to see if this sequence helps control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with rhabdomyosarcoma (a type of muscle cancer) in your nose or sinuses.
- You have not received any previous treatment for this cancer.
- Your cancer has not spread to other parts of the body.
- Your doctors expect you to live at least 6 more months.
- You are generally well enough to be up and about at least half the day (ECOG score 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatment approaches for a specific type of nasal and sinus cancer (adenoid cystic carcinoma) after surgery. Eligible patients have already had surgery with clear margins and will be randomly assigned to either observe closely or receive additional radiation therapy to see which approach works better.
This trial tests whether adding targeted radiation (SBRT) to chemotherapy and an immunotherapy drug can help people with metastatic nasopharyngeal cancer live longer and control tumors. It may help by combining local tumor treatment with whole-body immune support.
This Phase 2 trial tests giving radiation and immunotherapy before surgery for mucosal melanoma in the nose/sinuses or rectum. It may help shrink the tumor and improve outcomes while aiming to control the disease locally and in nearby areas.
This trial tests whether adding targeted radiation (SBRT) to a combination of chemotherapy and immunotherapy before surgery can improve outcomes for people with advanced mouth or throat cancer. It aims to shrink the tumor more effectively before removal.
This Phase 1 trial tests a new plan that combines immunotherapy with surgery, plus a targeted radiation treatment called IORT. It is for people whose head and neck squamous cell cancer has come back or never fully went away and can be operated on. The goal is to shrink or control the cancer and see how safe the approach is.
This trial compares two treatment plans for newly diagnosed, operable nasopharyngeal cancer: adding surgery plus targeted chemoradiation versus standard chemoradiation alone. It aims to see whether the surgery-based plan improves control of the cancer and related outcomes.
Hear when a new ORR trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.